ALDH7A1 and pulmonary arterial hypertension: Currently, selective PDE inhibitors have been investigated for the treatment of a wide range of diseases, such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension and erectile dysfunction etc [19].